nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—DDC—nerve—acquired immunodeficiency syndrome	0.0278	0.157	CbGeAlD
Methyldopa—DDC—blood plasma—acquired immunodeficiency syndrome	0.021	0.119	CbGeAlD
Methyldopa—COMT—blood plasma—acquired immunodeficiency syndrome	0.0139	0.0785	CbGeAlD
Methyldopa—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00709	0.04	CbGeAlD
Methyldopa—DDC—lung—acquired immunodeficiency syndrome	0.00676	0.0381	CbGeAlD
Methyldopa—COMT—skin of body—acquired immunodeficiency syndrome	0.00669	0.0377	CbGeAlD
Methyldopa—DDC—nervous system—acquired immunodeficiency syndrome	0.00626	0.0353	CbGeAlD
Methyldopa—DDC—central nervous system—acquired immunodeficiency syndrome	0.00603	0.034	CbGeAlD
Methyldopa—SLC15A1—digestive system—acquired immunodeficiency syndrome	0.00602	0.0339	CbGeAlD
Methyldopa—COMT—digestive system—acquired immunodeficiency syndrome	0.00535	0.0302	CbGeAlD
Methyldopa—SLC15A1—vagina—acquired immunodeficiency syndrome	0.00531	0.03	CbGeAlD
Methyldopa—COMT—blood—acquired immunodeficiency syndrome	0.0051	0.0288	CbGeAlD
Methyldopa—COMT—bone marrow—acquired immunodeficiency syndrome	0.00493	0.0278	CbGeAlD
Methyldopa—COMT—spinal cord—acquired immunodeficiency syndrome	0.00491	0.0277	CbGeAlD
Methyldopa—DDC—brain—acquired immunodeficiency syndrome	0.00478	0.027	CbGeAlD
Methyldopa—COMT—vagina—acquired immunodeficiency syndrome	0.00473	0.0267	CbGeAlD
Methyldopa—DDC—lymph node—acquired immunodeficiency syndrome	0.00462	0.0261	CbGeAlD
Methyldopa—COMT—lung—acquired immunodeficiency syndrome	0.00447	0.0252	CbGeAlD
Methyldopa—COMT—nervous system—acquired immunodeficiency syndrome	0.00414	0.0233	CbGeAlD
Methyldopa—COMT—central nervous system—acquired immunodeficiency syndrome	0.00399	0.0225	CbGeAlD
Methyldopa—COMT—brain—acquired immunodeficiency syndrome	0.00316	0.0178	CbGeAlD
Methyldopa—COMT—lymph node—acquired immunodeficiency syndrome	0.00306	0.0172	CbGeAlD
Methyldopa—ADRA2A—blood—acquired immunodeficiency syndrome	0.0026	0.0146	CbGeAlD
Methyldopa—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.0025	0.0141	CbGeAlD
Methyldopa—ADRA2A—vagina—acquired immunodeficiency syndrome	0.00241	0.0136	CbGeAlD
Methyldopa—ADRA2A—lung—acquired immunodeficiency syndrome	0.00228	0.0128	CbGeAlD
Methyldopa—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.00211	0.0119	CbGeAlD
Methyldopa—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.00203	0.0114	CbGeAlD
Methyldopa—ADRA2A—brain—acquired immunodeficiency syndrome	0.00161	0.00909	CbGeAlD
Methyldopa—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.00156	0.00878	CbGeAlD
Methyldopa—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.00147	0.00179	CcSEcCtD
Methyldopa—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00147	0.00179	CcSEcCtD
Methyldopa—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.00147	0.00178	CcSEcCtD
Methyldopa—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00146	0.00178	CcSEcCtD
Methyldopa—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00146	0.00177	CcSEcCtD
Methyldopa—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00145	0.00177	CcSEcCtD
Methyldopa—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00177	CcSEcCtD
Methyldopa—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00144	0.00175	CcSEcCtD
Methyldopa—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.00144	0.00175	CcSEcCtD
Methyldopa—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.00143	0.00174	CcSEcCtD
Methyldopa—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.00143	0.00174	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00142	0.00173	CcSEcCtD
Methyldopa—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.00141	0.00171	CcSEcCtD
Methyldopa—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.0014	0.00171	CcSEcCtD
Methyldopa—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.00139	0.00169	CcSEcCtD
Methyldopa—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.00139	0.00169	CcSEcCtD
Methyldopa—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.00138	0.00168	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00138	0.00168	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00137	0.00167	CcSEcCtD
Methyldopa—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00137	0.00167	CcSEcCtD
Methyldopa—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.00137	0.00166	CcSEcCtD
Methyldopa—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.00137	0.00166	CcSEcCtD
Methyldopa—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.00137	0.00166	CcSEcCtD
Methyldopa—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00137	0.00166	CcSEcCtD
Methyldopa—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.00136	0.00165	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00136	0.00165	CcSEcCtD
Methyldopa—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.00136	0.00165	CcSEcCtD
Methyldopa—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.00135	0.00165	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00135	0.00165	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00135	0.00164	CcSEcCtD
Methyldopa—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.00133	0.00162	CcSEcCtD
Methyldopa—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.00162	CcSEcCtD
Methyldopa—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.00133	0.00162	CcSEcCtD
Methyldopa—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.00132	0.0016	CcSEcCtD
Methyldopa—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00131	0.00159	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00131	0.00159	CcSEcCtD
Methyldopa—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.0013	0.00159	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.0013	0.00158	CcSEcCtD
Methyldopa—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.0013	0.00158	CcSEcCtD
Methyldopa—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.00129	0.00157	CcSEcCtD
Methyldopa—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00129	0.00157	CcSEcCtD
Methyldopa—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00129	0.00157	CcSEcCtD
Methyldopa—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00129	0.00156	CcSEcCtD
Methyldopa—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00128	0.00156	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00128	0.00156	CcSEcCtD
Methyldopa—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00156	CcSEcCtD
Methyldopa—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00128	0.00156	CcSEcCtD
Methyldopa—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00127	0.00155	CcSEcCtD
Methyldopa—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.00127	0.00155	CcSEcCtD
Methyldopa—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00127	0.00155	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00126	0.00154	CcSEcCtD
Methyldopa—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.00153	CcSEcCtD
Methyldopa—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00125	0.00152	CcSEcCtD
Methyldopa—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00125	0.00152	CcSEcCtD
Methyldopa—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00124	0.00151	CcSEcCtD
Methyldopa—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00123	0.0015	CcSEcCtD
Methyldopa—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.00123	0.0015	CcSEcCtD
Methyldopa—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00122	0.00148	CcSEcCtD
Methyldopa—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00121	0.00147	CcSEcCtD
Methyldopa—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00147	CcSEcCtD
Methyldopa—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00147	CcSEcCtD
Methyldopa—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.0012	0.00146	CcSEcCtD
Methyldopa—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.0012	0.00146	CcSEcCtD
Methyldopa—Rash—Amprenavir—acquired immunodeficiency syndrome	0.0012	0.00146	CcSEcCtD
Methyldopa—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.0012	0.00146	CcSEcCtD
Methyldopa—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.0012	0.00145	CcSEcCtD
Methyldopa—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.0012	0.00145	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00119	0.00145	CcSEcCtD
Methyldopa—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00119	0.00145	CcSEcCtD
Methyldopa—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00119	0.00145	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.00145	CcSEcCtD
Methyldopa—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00119	0.00145	CcSEcCtD
Methyldopa—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00119	0.00144	CcSEcCtD
Methyldopa—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00119	0.00144	CcSEcCtD
Methyldopa—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.00118	0.00144	CcSEcCtD
Methyldopa—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00118	0.00144	CcSEcCtD
Methyldopa—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00118	0.00143	CcSEcCtD
Methyldopa—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00117	0.00143	CcSEcCtD
Methyldopa—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00115	0.0014	CcSEcCtD
Methyldopa—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00115	0.0014	CcSEcCtD
Methyldopa—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00115	0.0014	CcSEcCtD
Methyldopa—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00113	0.00138	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00138	CcSEcCtD
Methyldopa—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.00113	0.00137	CcSEcCtD
Methyldopa—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00137	CcSEcCtD
Methyldopa—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00137	CcSEcCtD
Methyldopa—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00112	0.00136	CcSEcCtD
Methyldopa—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00112	0.00136	CcSEcCtD
Methyldopa—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00112	0.00136	CcSEcCtD
Methyldopa—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00136	CcSEcCtD
Methyldopa—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00111	0.00135	CcSEcCtD
Methyldopa—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00111	0.00135	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00111	0.00135	CcSEcCtD
Methyldopa—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.0011	0.00134	CcSEcCtD
Methyldopa—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.0011	0.00134	CcSEcCtD
Methyldopa—Rash—Didanosine—acquired immunodeficiency syndrome	0.0011	0.00133	CcSEcCtD
Methyldopa—Infection—Delavirdine—acquired immunodeficiency syndrome	0.0011	0.00133	CcSEcCtD
Methyldopa—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00109	0.00133	CcSEcCtD
Methyldopa—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00109	0.00133	CcSEcCtD
Methyldopa—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00109	0.00133	CcSEcCtD
Methyldopa—Headache—Didanosine—acquired immunodeficiency syndrome	0.00109	0.00132	CcSEcCtD
Methyldopa—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00109	0.00132	CcSEcCtD
Methyldopa—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00108	0.00132	CcSEcCtD
Methyldopa—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.00131	CcSEcCtD
Methyldopa—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00108	0.00131	CcSEcCtD
Methyldopa—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00107	0.0013	CcSEcCtD
Methyldopa—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00107	0.0013	CcSEcCtD
Methyldopa—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00107	0.0013	CcSEcCtD
Methyldopa—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00129	CcSEcCtD
Methyldopa—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00129	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.00128	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00128	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.00128	CcSEcCtD
Methyldopa—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00104	0.00127	CcSEcCtD
Methyldopa—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00104	0.00126	CcSEcCtD
Methyldopa—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00104	0.00126	CcSEcCtD
Methyldopa—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.00126	CcSEcCtD
Methyldopa—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00103	0.00125	CcSEcCtD
Methyldopa—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00103	0.00125	CcSEcCtD
Methyldopa—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00125	CcSEcCtD
Methyldopa—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00124	CcSEcCtD
Methyldopa—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00124	CcSEcCtD
Methyldopa—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00102	0.00124	CcSEcCtD
Methyldopa—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00102	0.00124	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00124	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.001	0.00122	CcSEcCtD
Methyldopa—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.001	0.00122	CcSEcCtD
Methyldopa—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.001	0.00121	CcSEcCtD
Methyldopa—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000998	0.00121	CcSEcCtD
Methyldopa—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000997	0.00121	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000995	0.00121	CcSEcCtD
Methyldopa—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000993	0.00121	CcSEcCtD
Methyldopa—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00099	0.0012	CcSEcCtD
Methyldopa—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00099	0.0012	CcSEcCtD
Methyldopa—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000985	0.0012	CcSEcCtD
Methyldopa—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000985	0.0012	CcSEcCtD
Methyldopa—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000984	0.0012	CcSEcCtD
Methyldopa—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000983	0.00119	CcSEcCtD
Methyldopa—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000981	0.00119	CcSEcCtD
Methyldopa—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000979	0.00119	CcSEcCtD
Methyldopa—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000976	0.00119	CcSEcCtD
Methyldopa—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000976	0.00119	CcSEcCtD
Methyldopa—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000975	0.00118	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00097	0.00118	CcSEcCtD
Methyldopa—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000964	0.00117	CcSEcCtD
Methyldopa—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000962	0.00117	CcSEcCtD
Methyldopa—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000962	0.00117	CcSEcCtD
Methyldopa—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000961	0.00117	CcSEcCtD
Methyldopa—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000959	0.00117	CcSEcCtD
Methyldopa—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000954	0.00116	CcSEcCtD
Methyldopa—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000953	0.00116	CcSEcCtD
Methyldopa—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000953	0.00116	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000952	0.00116	CcSEcCtD
Methyldopa—Rash—Stavudine—acquired immunodeficiency syndrome	0.000951	0.00116	CcSEcCtD
Methyldopa—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00095	0.00115	CcSEcCtD
Methyldopa—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000948	0.00115	CcSEcCtD
Methyldopa—Headache—Stavudine—acquired immunodeficiency syndrome	0.000945	0.00115	CcSEcCtD
Methyldopa—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000945	0.00115	CcSEcCtD
Methyldopa—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000943	0.00115	CcSEcCtD
Methyldopa—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000941	0.00114	CcSEcCtD
Methyldopa—Rash—Abacavir—acquired immunodeficiency syndrome	0.000937	0.00114	CcSEcCtD
Methyldopa—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000936	0.00114	CcSEcCtD
Methyldopa—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000936	0.00114	CcSEcCtD
Methyldopa—Headache—Abacavir—acquired immunodeficiency syndrome	0.000931	0.00113	CcSEcCtD
Methyldopa—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00093	0.00113	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000929	0.00113	CcSEcCtD
Methyldopa—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000928	0.00113	CcSEcCtD
Methyldopa—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000918	0.00112	CcSEcCtD
Methyldopa—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000916	0.00111	CcSEcCtD
Methyldopa—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000915	0.00111	CcSEcCtD
Methyldopa—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000911	0.00111	CcSEcCtD
Methyldopa—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000909	0.0011	CcSEcCtD
Methyldopa—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000899	0.00109	CcSEcCtD
Methyldopa—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000898	0.00109	CcSEcCtD
Methyldopa—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000897	0.00109	CcSEcCtD
Methyldopa—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000896	0.00109	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000894	0.00109	CcSEcCtD
Methyldopa—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000883	0.00107	CcSEcCtD
Methyldopa—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000881	0.00107	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00088	0.00107	CcSEcCtD
Methyldopa—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000875	0.00106	CcSEcCtD
Methyldopa—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000872	0.00106	CcSEcCtD
Methyldopa—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000871	0.00106	CcSEcCtD
Methyldopa—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000867	0.00105	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000853	0.00104	CcSEcCtD
Methyldopa—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000849	0.00103	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000847	0.00103	CcSEcCtD
Methyldopa—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00084	0.00102	CcSEcCtD
Methyldopa—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000839	0.00102	CcSEcCtD
Methyldopa—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000834	0.00101	CcSEcCtD
Methyldopa—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000834	0.00101	CcSEcCtD
Methyldopa—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000827	0.001	CcSEcCtD
Methyldopa—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000827	0.001	CcSEcCtD
Methyldopa—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000826	0.001	CcSEcCtD
Methyldopa—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000821	0.000998	CcSEcCtD
Methyldopa—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000812	0.000987	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000808	0.000982	CcSEcCtD
Methyldopa—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000806	0.00098	CcSEcCtD
Methyldopa—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000806	0.000979	CcSEcCtD
Methyldopa—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.0008	0.000973	CcSEcCtD
Methyldopa—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000791	0.000961	CcSEcCtD
Methyldopa—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000788	0.000958	CcSEcCtD
Methyldopa—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000779	0.000947	CcSEcCtD
Methyldopa—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000776	0.000943	CcSEcCtD
Methyldopa—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000775	0.000942	CcSEcCtD
Methyldopa—Rash—Indinavir—acquired immunodeficiency syndrome	0.000769	0.000934	CcSEcCtD
Methyldopa—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000768	0.000934	CcSEcCtD
Methyldopa—Headache—Indinavir—acquired immunodeficiency syndrome	0.000764	0.000928	CcSEcCtD
Methyldopa—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000762	0.000926	CcSEcCtD
Methyldopa—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000754	0.000917	CcSEcCtD
Methyldopa—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000751	0.000913	CcSEcCtD
Methyldopa—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00074	0.000899	CcSEcCtD
Methyldopa—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000732	0.00089	CcSEcCtD
Methyldopa—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000731	0.000889	CcSEcCtD
Methyldopa—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000729	0.000886	CcSEcCtD
Methyldopa—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000726	0.000883	CcSEcCtD
Methyldopa—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000726	0.000882	CcSEcCtD
Methyldopa—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000724	0.00088	CcSEcCtD
Methyldopa—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000723	0.000879	CcSEcCtD
Methyldopa—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000722	0.000877	CcSEcCtD
Methyldopa—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000704	0.000856	CcSEcCtD
Methyldopa—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000701	0.000852	CcSEcCtD
Methyldopa—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000697	0.000848	CcSEcCtD
Methyldopa—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000695	0.000845	CcSEcCtD
Methyldopa—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000694	0.000844	CcSEcCtD
Methyldopa—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000691	0.000839	CcSEcCtD
Methyldopa—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00069	0.000838	CcSEcCtD
Methyldopa—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000684	0.000832	CcSEcCtD
Methyldopa—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000674	0.000819	CcSEcCtD
Methyldopa—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000671	0.000816	CcSEcCtD
Methyldopa—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000671	0.000816	CcSEcCtD
Methyldopa—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000655	0.000796	CcSEcCtD
Methyldopa—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000649	0.000789	CcSEcCtD
Methyldopa—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000648	0.000788	CcSEcCtD
Methyldopa—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000643	0.000781	CcSEcCtD
Methyldopa—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000642	0.00078	CcSEcCtD
Methyldopa—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00064	0.000778	CcSEcCtD
Methyldopa—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000639	0.000776	CcSEcCtD
Methyldopa—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000624	0.000758	CcSEcCtD
Methyldopa—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000619	0.000752	CcSEcCtD
Methyldopa—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000619	0.000752	CcSEcCtD
Methyldopa—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000618	0.000751	CcSEcCtD
Methyldopa—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000615	0.000747	CcSEcCtD
Methyldopa—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000605	0.000736	CcSEcCtD
Methyldopa—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000595	0.000723	CcSEcCtD
Methyldopa—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00059	0.000717	CcSEcCtD
Methyldopa—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00059	0.000717	CcSEcCtD
Methyldopa—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000586	0.000713	CcSEcCtD
Methyldopa—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000583	0.000708	CcSEcCtD
Methyldopa—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000556	0.000676	CcSEcCtD
